The hypothesis is that aPL (first hit) only increases the thrombophilic risk while the thrombosis will occur in the presence of another thrombophilic conditions (second hit), such as inflammation and infection [22, 48]. The gene discussed is FASLG; the disease is deep vein thrombosis.